SCHEMBL8934594

SCHEMBL8934594

Oc1ccc(C2C(c3ccccc3)=COc3cc(O)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
ESR1 P03372 4/20 0.41
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
CASP1 P29466 1/20 0.36
BRCA1 P38398 1/20 0.36
STAT6 P42226 1/20 0.36
CASP7 P55210 1/20 0.36
HBB P68871 1/20 0.36
HIF1A Q16665 1/20 0.36
MECP2 P51608 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13302782 0.81 ALOX5 (0.37) ESR2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL7546321 0.77 CYP2C9 (0.34) ESR2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL28339729 0.74 ESR2 (0.44) ESR2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL19851151 0.72 MEN1 (0.64) ESR2MEN1KMT2AALDH1A1HSD17B10
Water SCHEMBL27862353 0.70 MEN1 (0.67) ESR2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL30208200 0.67 KDM4E (0.42) ESR2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL27973276 0.67 MEN1 (0.58) ESR2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL17369771 0.67 ALDH1A1 (0.48) ESR2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL27512594 0.64 MAOA (0.52) ESR2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL29089886 0.64 ALDH1A1 (0.54) ESR2MEN1KMT2AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed